Niemann-Pick’s disease type B and brain iron accumulation

Abstract

Background: Niemann-Pick’s type B (NP-B) disease is a rare, autosomal recessive visceral storage disorder related to a lysosomal accumulation of sphingomyelin, which is caused by mutations in the sphingomyelinase gene, SMPD1.

Case report: We present a boy who had normal early development, but from one year of age, he showed progressive manifestations of hepatosplenomegaly, somatomotor retardation and cardiopulmonary dysfunction. The activity of the sphingomyelinase enzyme was very low in his fibroblasts. He died at 17 years of age from cardio-respiratory insufficiency. Gross pathology and histology of the internal organs were compatible with Niemann-Pick’s disease. His brain and spinal cord displayed no signs of storage disease, confirming the subtype of NP-B. Unexpectedly, however, significant accumulation of iron was seen in the substantia nigra, subthalamic nuclei, putamen, globus pallidus and some cortical regions accompanied by axonal spheroids. Brain iron accumulation is the hallmark of a disease group termed neurodegeneration with brain iron accumulation (NBIA). Sequencing of the known NBIA disease genes was unsuccessful in the proband’s DNA isolated from formalin-fixed, paraffin-embedded blocks, but both asymptomatic parents were heterozygous carriers of the same c19orf12 deletion.

Conclusions: This case initially raised the question as to whether two rare autosomal recessive disorders, NP-B and a subtype of NBIA could have co-occurred in our patient, or the lipid dysmetabolism due to sphingomyelinase deficiency caused secondary brain iron accumulation. Genetic analyses in the parents suggested the former possibility by identifying a c19orf12 gene deletion known to underlie in homozygous state Mitochondrial Membrane Protein Associated Neurodegeneration.

Keywords

Niemann-Pick’s type B / Lipid metabolism / Brain iron accumulation

ACKNOWLEDGEMENTS

JMM and RB were supported by the National Brain Research Foundation KTIA_13_NAP-A-III/6. No other grant support was directly involved in this study. The present scientific contribution is dedicated to the 650th anniversary of the foundation of the University of Pecs, Hungary.

CONFLICTS OF INTEREST DISCLOSURE

The authors declare no conflicts of interest.

References

[1] Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med. 2003; 348(1): 33-40. PMid: 12510040. https://doi.org/10.1056/NEJMoa020817

[2] Hayflick SJ. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Curr Opin Pediatr. 2003; 15(6): 572-7. PMid: 14631201. https://doi.org/10.1097/00008480-200312000-00005

[3] Schneider SA, Dusek P, Hardy J, et al. Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA). Curr Neuropharmacol. 2013; 11(1): 59-79. https://doi.org/10.2174/157015913804999469

[4] Arber CE, Li A, Houlden H, et al. Review: Insights into molecular mechanisms of disease in neurodegeneration with brain ironaccumu-lation: unifying theories. Neuropathol Appl Neurobiol. 2016; 42(3): 220-41. https://doi.org/10.1111/nan.12242

[5] Grosz Z, Bencsik R, Lengyel A, et al. Genetic and phenotypic characteristics of Hungarian patients with Neurodegeneration with Brain Iron Accumulation (NBIA). Eur J Neurol. 2015; 22(Suppl.1): 147-147.

[6] Cassiman D, Packman S, Bembi B, et al. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new cases. Mol Genet Metab. 2016; 118(3): 206-13. https://doi.org/10.1016/j.ymgme.2016.05.001

[7] Hartig MB, Iuso A, Haack T, et al. Absence of an orphan mito-chondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet. 2011; 89(4): 543-50. https://doi.org/10.1016/j.ajhg.2011.09.007

[8] Hartig M, Prokisch H, Meitinger T, et al. Mitochondrial membrane protein-associated neurodegeneration (MPAN). Int Rev Neurobiol. 2013; 110: 73-84. https://doi.org/10.1016/B978-0-12-410502-7.00004-1

[9] Hogarth P, Gregory A, Kruer MC, et al. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology. 2013; 80(3): 268-75. https://doi.org/10.1212/WNL.0b013e31827e07be

[10] Kurian MA, Morgan NV, MacPherson L, et al. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G 6 gene (PLAN). Neurology. 2008; 70(18): 1623-9. https://doi.org/10.1212/01.wnl.0000310986.48286.8e

[11] Dusi S, Valletta L, Haack TB, et al. Exome sequence reveals mu-tations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. Am J Hum Genet. 2014; 94(1): 11-22. https://doi.org/10.1016/j.ajhg.2013.11.008

[12] Hayflick SJ, Kruer MC, Gregory A, et al. β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain. 2013; 136(Pt 6): 1708-17. https://doi.org/10.1093/brain/awt095

[13] Stein P, Yu H, Jain D, et al. Hyperferritinemia and iron overload in type 1 Gaucher disease. Am J Hematol. 2010; 85(7): 472-6. https://doi.org/10.1002/ajh.21721

[14] Heidari M, Gerami SH, Bassett B, et al. UK Brain Expression Consortium (UKBEC), Olynyk JK, Trinder D, Johnstone DM, Milward EA. Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases. Rare Dis. 2016; 4(1): e1198458. https://doi.org/10.1080/21675511.2016.1198458

[15] Kruer MC, Hiken M, Gregory A, et al. Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurode-generation. Brain. 2011; 134(Pt 4): 947-58. https://doi.org/10.1093/brain/awr042

[16] Kruer MC. The neuropathology of neurodegeneration with brain iron accumulation. Int Rev Neurobiol. 2013; 110: 165-94. https://doi.org/10.1016/B978-0-12-410502-7.00009-0